Related Experiment Video
Updated: May 25, 2026
09:43
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
New and future therapies for lupus nephritis
1Presbyterian Hospital, New York, NY 10032, USA. gba2@columbia.edu
Cleveland Clinic Journal of Medicine
|February 4, 2012
Summary
Oral mycophenolate (CellCept) and intravenous cyclophosphamide (Cytoxan) show similar efficacy for lupus nephritis. Mycophenolate offers a less toxic alternative, highlighting the need for personalized treatment strategies.
Area of Science:
- Nephrology
- Immunology
- Rheumatology
Background:
- Lupus nephritis treatment has evolved significantly over the last decade.
- Cyclophosphamide has been a traditional first-line therapy, but concerns regarding toxicity exist.
Purpose of the Study:
- To compare the efficacy and toxicity of oral mycophenolate versus intravenous cyclophosphamide for lupus nephritis.
- To discuss the evolving landscape of lupus nephritis treatment.
Main Methods:
- Review of randomized controlled trials from the past decade.
- Comparative analysis of treatment outcomes, including efficacy and adverse events.
Main Results:
- Oral mycophenolate demonstrates comparable efficacy to intravenous cyclophosphamide in treating lupus nephritis.
- Mycophenolate is associated with reduced toxicity compared to cyclophosphamide.
Conclusions:
- Oral mycophenolate is a viable and less toxic first-line therapy option for lupus nephritis.
- Further research into agents like rituximab and novel immunomodulators is ongoing.
- Individualized treatment approaches are crucial for managing lupus nephritis effectively.
More Related Videos
Related Concept Videos
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...